Tenderwize
Back to tender search

Tiotropiumbromid (ATC R03BB04) excluding dry powder inhaler capsules

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2028 · 591 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tiotropiumbromid (ATC: R03BB04 - außer in der Darreichungsform HPI)

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume commitments; revenue depends on actual prescriptions and discount impact.

Notice explicitly states it is not a public procurement; legal recourse under GWB may be limited.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Tiotropiumbromid medicinal products (excluding dry powder inhaler capsules)
  • Conclusion of non-exclusive rebate agreements under German Social Code (§130a Abs. 8 SGB V)
Show full summary

Non-exclusive discount agreement open-house model for Tiotropiumbromid (ATC R03BB04, excluding dry powder inhaler capsules) under §130a Abs. 8 SGB V. Any eligible pharmaceutical company can join anytime until contract end. Contract duration max 24 months from earliest start 01.06.2026, ending 31.05.2028. No procurement law application; voluntary transparency publication.

Risks

No estimated value or volume commitments; revenue depends on actual prescriptions and discount impact.

Notice explicitly states it is not a public procurement; legal recourse under GWB may be limited.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Pharmaceutical company must be eligible to manufacture/market the product

Administrative

  • Complete and sign participation documents
  • Submit signed contract via qualified electronic signature or postal mail

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all eligible participants are accepted.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Tiotropiumbromid (ATC R03BB04) excluding dry powder inhaler capsules

Non-exclusive discount agreement for finished medicinal products containing Tiotropiumbromid (ATC R03BB04) in all dosage forms except hard capsules with powder for inhalation. Open-house model; each eligible pharmaceutical company can join at any time under identical conditions. No exclusivity, no individual negotiations. Contract ends 31.05.2028 regardless of start date.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all eligible participants are accepted.

Deadline

Deadline Mar 30, 2028

Procurement Details

Publication date
19 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
266223-2026

Documents (1)

Similar tenders